Research ArticleExperimental Studies
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH and MARKUS WALLWIENER
Anticancer Research April 2023, 43 (4) 1449-1454; DOI: https://doi.org/10.21873/anticanres.16293
STEFAN STEFANOVIC
1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;
RALPH WIRTZ
2Stratifyer Molecular Pathology GmbH, Cologne, Germany;
MARC SÜTTERLIN
1Department of Gynecology and Obstetrics, Mannheim University Hospital, University of Heidelberg, Mannheim, Germany;
UROS KARIC
3Medical Statistics, IMDI Science Center, Belgrade, Serbia;
4Hospital for Infectious and Tropical Diseases, Belgrade University School of Medicine, Belgrade, Serbia;
ANDREAS SCHNEEWEISS
5National Center for Tumor Diseases, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany;
6German Cancer Research Center (DKFZ), Heidelberg, Germany;
THOMAS M. DEUTSCH
7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany
MARKUS WALLWIENER
7Department of Gynecology and Obstetrics, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER
Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293
Cut-off Analysis of HLA-A and HLA-B/C Expression as a Potential Prognosticator of Favorable Survival in Patients With Metastatic Breast Cancer
STEFAN STEFANOVIC, RALPH WIRTZ, MARC SÜTTERLIN, UROS KARIC, ANDREAS SCHNEEWEISS, THOMAS M. DEUTSCH, MARKUS WALLWIENER
Anticancer Research Apr 2023, 43 (4) 1449-1454; DOI: 10.21873/anticanres.16293
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.